Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study

Matthew Hicks, Olivia Hicks, Ryan Bradley, Heather Zwickey

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (31)

  1. Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials. 2026-01-01 · Expand citations
  2. Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study. 2024-08-01 · Expand citations
  3. Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial. 2023-09-05 · Expand citations
  4. HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer. 2023-09-01 · Expand citations
  5. Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication. 2023-09-01 · Expand citations
  6. Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder. 2023-06-01 · Expand citations
  7. Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial. 2023-02-01 · Expand citations
  8. Group psychedelic therapy: empirical estimates of cost-savings and improved access. 2023-01-01 · Expand citations
  9. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. 2021-05-01 · Expand citations
  10. Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. 2020-10-01 · Expand citations
  11. The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act. 2018-11-01 · Expand citations
  12. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  13. Psychometric evaluation of the altered states of consciousness rating scale (OAV). 2010-08-31 · Expand citations
  14. OpenAlex W1857921554
  15. OpenAlex W2001002980
  16. OpenAlex W2014261733
  17. OpenAlex W2017152382
  18. OpenAlex W2114613490
  19. OpenAlex W2793644042
  20. OpenAlex W2793808927
  21. OpenAlex W2928737933
  22. OpenAlex W4214531716
  23. OpenAlex W4220841869
  24. OpenAlex W4292410066
  25. OpenAlex W4295789857
  26. OpenAlex W4309926403
  27. OpenAlex W4311508922
  28. OpenAlex W4386828200
  29. OpenAlex W4405406855
  30. OpenAlex W4406240577
  31. OpenAlex W4410309291

Cited by — these papers cite this paper (1)

  1. Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico 2026-06-17 · Expand citations